This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Avidbiotics Corporation, Life Technologies Corporation. Active years: 2014-2018.
Company Filing History:
Years Active: 2014-2018
Title: Gregory Govoni: Innovator in Microbial Detection and Bacteriocin Development
Introduction
Gregory Govoni is a notable inventor based in San Carlos, CA (US), recognized for his contributions to the fields of microbial detection and bacteriocin development. With a total of 4 patents, his work focuses on innovative solutions for capturing and lysing microorganisms from various liquids.
Latest Patents
Govoni's latest patents include a device for the capture and lysis of microorganisms from liquids, which provides methods for detecting microbial contaminants such as bacteria and fungi in fluids like drinking water and pharmaceutical solutions. This invention features filtration devices designed for the capture and processing of microorganisms, along with improved methods for recovery, lysis, and detection using a combination of physical disruption with small beads and lysis solutions. Another significant patent is related to diffocins, which involves the discovery and isolation of genes encoding R-type high molecular weight bacteriocins that specifically target dangerous pathogens. This invention offers a potent bactericidal agent with enhanced thermal and pH stability, aimed at selectively killing harmful bacteria in the gastrointestinal tract.
Career Highlights
Throughout his career, Govoni has worked with prominent companies such as Life Technologies Corporation and Avidbiotics Corporation. His innovative approaches have significantly advanced the understanding and application of microbial detection technologies.
Collaborations
Some of his notable coworkers include Kevin Hacker and Mariela Cuadras, who have contributed to his research and development efforts.
Conclusion
Gregory Govoni's work exemplifies the intersection of innovation and practical application in the field of microbial detection and bacteriocin development. His contributions continue to impact the scientific community and improve public health outcomes.